08:00 , Jan 20, 2014 |  BC Week In Review  |  Clinical News

NIRsupreme Ridaforolimus-Eluting Coronary Stent System: Phase II started

Medinol began the single-blind, international Phase II BIONICS trial to compare NIRsupreme Ridaforolimus-Eluting Coronary Stent System vs. Endeavor Resolute Zotarolimus-Eluting Stent in about 1,900 patients. The start of the trial - along with the start...
08:00 , Jan 20, 2014 |  BC Week In Review  |  Clinical News

NIRsupreme Ridaforolimus-Eluting Coronary Stent System: Phase II started

Medinol began the single-blind, international Phase II NIREUS trial to compare NIRsupreme Ridaforolimus-Eluting Coronary Stent System vs. Endeavor Resolute Zotarolimus-Eluting Stent in about 300 patients. The start of the trial - along with the start...